drugset / Trial / NCT00735371
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study will evaluate the efficacy of LDX treatment group compared to placebo on the change from Baseline ADHD-RS-IV score at endpoint.
Timeline
- Start
- 2008-10-08
- Primary completion
- 2009-04-06
- Completion
- 2009-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lisdexamfetamine Dimesylate | Small molecule | 30 mg | — |
| Comparator | Lisdexamfetamine Dimesylate | Small molecule | 50 mg | — |
| Comparator | Lisdexamfetamine Dimesylate | Small molecule | 70 mg | — |